Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa

Journal of Surgical Research

Volumn 61, Issue 2, 1996, Pages 543-548

  Li, Jian Ming ^a   Podolsky, Robert S ^a   Rohrer, Michael J ^a   Cutler, Bruce S ^a   Massie, Mitchell T ^a   Barnard, Marc R ^a   Michelson, Alan D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; VIRUS INFECTION;

EID: 0029870922     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0161     Document Type: Article

References (41)

1. Fitzgerald, L. A., and Phillips, D. R. Structure and function of platelet membrane glycoproteins. In T. J. Kunicki and J. N. George (Eds.), Platelet Immunobiology: Molecular and Clinical Aspects. Philadelphia: Lippincott, 1989. Pp. 9-30.
2. Weiss, H. J., Turitto, V. T., and Baumgartner, H. R. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood: I. Shear rate-dependent decrease of adhesion in Bernard-Soulier syndrome. J. Lab. Clin. Med. 92: 750, 1978.
3. Roth, G. J. Platelet and blood vessels: The adhesion event. Immunol. Today 13: 100, 1992.
4. Parise, L. V., and Phillips, D. R. Reconstitution of the purified platelet fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex. J. Biol. Chem. 260: 10698, 1985.
5. Pytela, R., Pierschbacher, M. D., Ginsberg, M. H., Plow, E. F., and Ruoslahti, E. Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 231: 1559, 1986.
6. George, J. N., Pickett, E. B., Saucerman, S., McEver, R. P., Kunicki, T. J., Kieffer, N., and Newman, P. J. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J. Clin. Invest. 78: 340, 1986.
7. Michelson, A. D., and Barnard, M. R. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 70: 1673, 1987.
8. Johnson, P. C., Sheppeck, R. A., Hribar, S. R., Bentz, M. L., Janosky, J., and Dickson, C. S. Inhibition of platelet retention on artificial microvascular grafts with monoclonal antibodies and a high affinity peptide directed against platelet membrane glycoproteins. Arterioscler. Thromb. 11: 552, 1991.
9. Greisler, H. P., Klosak, J. J., Steinam, S. J., Lam, T. M., Burgess, W. H., and Kim, D. U. Effects of class I heparin binding growth factor and fibronectin on platelet adhesion and aggregation. J. Vasc. Surg. 11: 665, 1990.
10. Rubin, B. G., McGraw, D. J., Sicard, G. A., and Santoro, S. A. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts. J. Vasc. Surg. 15: 683, 1992.
11. Ryu, G., Han, D., Kim, Y., and Min, B. Albumin immobilized polyurethane and its blood compatibility. ASAIO Trans. 38: M644, 1992.
12. Schleimer, R. P., Sterbinsky, S. A., Kaiser, J., et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148: 1086, 1992.
13. Niu, X. f., Smith, C. W., and Kebes, P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74: 1133, 1994.
14. 2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Lab. Invest. 42: 366, 1980.
15. Czervionke, R. L., Hoak, J. C., and Fry, G. L. Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall. J. Clin. Invest. 62: 847, 1978.
16. Hickey, N. C., Thomson, I. A., Shearman, C. P., and Simms, M. H. Aggressive arterial reconstruction for critical lower limb ischaemia. Br. J. Surg. 78: 1476, 1991.
17. Petch, M. C. Coronary bypasses 10 years on. About two in five will occlude. Br. Med. J. 303: 661, 1991.
18. Li, J. M., Menconi, M. J., Wheeler, H. B., Rohrer, M. J., Klassen, V. K., Ansell, J. E., and Appel, M. C. Precoating expanded polytetrafluoroethylene grafts alters production of endothelial cell-derived thrombomodulators. J. Vasc. Surg. 15: 1010, 1992.
19. Li, J. M., Menconi, M. J., Wheeler, H. B., Rohrer, M. J., Anderson, F. A., Jr., and Cutler, B. S. Experimental femoral vein reconstruction with expanded polytetrafluoroethylene grafts seeded with endothelial cells. Cardiovasc. Surg. 1: 362, 1993.
20. Li, J. M., Fenton, R. A., Cutler, B. S., and Dobson, J. G., Jr. Adenosine enhances nitric oxide production by vascular endothelial cells. Am. J. Physiol. 269 (Cell Physiol. 38): C519, 1995.
21. Shattil, S. J., Hoxie, J. A., Cunningham, M., and Brass, L. F. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J. Biol. Chem. 260: 11107, 1985.
22. Coller, B. S., Peerschke, E. I., Scudder, L. E., and Sullivan, C. A. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenia-like state in normal platelets and binding to glycoprotein IIb and/or IIIa. J. Clin. Invest. 72: 325, 1983.
23. Coller, B. S., Peerschke, E. I., Scudder, L. E., and Sullivan, C. A. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 61: 99, 1983.
24. Michelson, A. D., Loscalzo, J., Melnick, B., Coller, B. S., and Handin, R. I. Partial characterization of a binding site for von Willebrand factor on glycocalicin. Blood 67: 19, 1986.
25. Michelson, A. D., Ellis, P. A., Barnard, M. R., Matic, G. B., Viles, A. F., and Kestin, A. S. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood 77: 770, 1991.
26. Michelson, A. D., Benoit, S. E., Kroll, M. H., Li, J. M., Rohrer, M. J., Kestin, A. S., and Barnard, M. R. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood 83: 3562, 1994.
27. Skinner, M. P., Lucas, C. M., Burns, G. F., Chesterman, C. N., and Berndt, M. C. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J. Biol. Chem. 266: 5371, 1991.
28. Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., and Bainton, D. F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell Biol. 101: 880, 1985.
29. Hsu-Lin, S-C., Berman, C. L., Furie, B. C., August, D., and Furie, B. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J. Biol. Chem. 259: 9121, 1984.
30. Knapp, W., Dorken, B., Rieber, P., Schmidt, R. E., Stein, H., von dem Borne, A. E. G. Kr. CD antigens 1989. Blood 74: 1448, 1989.
31. McEver, R. P. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 16: 73, 1990.
32. Heilman, E., Friese, P., Anderson, S., George, J. N., Hanson, S. R., Burstein, S. A., and Dale, G. L. Biotinylated platelets: A new approach to the measurement of platelet life span. Br. J. Haematol. 85: 729, 1993.
33. Zilla, P., von Oppell, U., and Deutsch, M. The endothelium: A key to the future. J. Card. Surg. 8: 32, 1993. [Review]
34. Weiss, H. J., Hawiger, J., Ruggeri, Z. M., Turitto, V. T., Thiagarajan, P., and Hoffman, T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb/IIIa complex at high shear rate. J. Clin. Invest. 83: 288, 1989.
35. 2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor. Blood 66: 1456, 1985.
36. Krupski, W. C., Bass, A., Kelly, A. B., Ruggeri, Z. M., Harker, L. A., and Hanson, S. R. Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons. J. Vasc. Surg. 17: 294, 1993.
37. Simoons, M. L., de Boer, M. J., van den Brand, M. J. B. M., et al. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. Circulation 89: 596, 1994.
38. Kelly, A. B., Marzec, U. M., Krupski, W., Bass, A., Cadroy, Y., Hanson, S. R., and Harker, L. A. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 77: 1006, 1991.
39. Moncada, S., and Vane, J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N. Engl. J. Med. 300: 1142, 1979.
40. Azrin, M. The use of antibodies in clinical cardiology. Am. Heart J. 124: 753, 1992.
41. Ryan, U. S., Mortara, M., and Whitaker, C. Methods for microcarrier culture of bovine pulmonary artery endothelial cells avoiding the use of enzymes. Tissue Cell 12: 619, 1980.